
Two groups of patients with cystic fibrosis were compared. The screened group, detected with an improved neonatal screening assay for immunoreactive trypsin, developed fewer chest infections requiring treatment and gained more weight than the unscreened group. Early diagnosis by screening seems to affect early morbidity.
Time Factors, Cystic Fibrosis, Body Weight, review, Infant, Newborn, Infant, weight gain, Pediatrics, cystic fibrosis, newborn, PEDIATRICS, Humans, Mass Screening, Comparative Study, controlled study, human, Queensland, immunoreactive trypsin, Follow-Up Studies
Time Factors, Cystic Fibrosis, Body Weight, review, Infant, Newborn, Infant, weight gain, Pediatrics, cystic fibrosis, newborn, PEDIATRICS, Humans, Mass Screening, Comparative Study, controlled study, human, Queensland, immunoreactive trypsin, Follow-Up Studies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 51 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
